96例急性脑梗死患者溶栓治疗的临床分析

目的观察尿激酶治疗急性脑梗死患者的临床疗效，以期进一步指导临床应用。方法对96例急性脑梗死患者随机分为两组：（1）静脉溶栓治疗组48例，应用尿激酶静脉溶栓治疗。（2）对照组48例，采用常规药物治疗。两组分别于治疗前、后根据据第4次全国脑血管病会议通过的神经功能缺损程度（SSS）评分标准进行评分，比较两组的有效率。结果溶拴组与对照组的有效率存在显著差异（P〈0．05）。结论静脉溶栓治疗急性脑梗死有较好的临床疗效，并能显著改善神经功能缺损症状，疗效优于对照组，值得临床进一步推广。

Clinial Analysis of about Curative Effect of Thrombolytic Therapy in 96 Patients with Acute Cerebral Infarction

Objective To observe the therapeutic effect of urokinase applied in acute cerebral infarction in order to direct its application. Methods 96 eases with acute cerebral infarction were randomly divided into treatment group and controlled group. 48 eases in treatment group were cured by umkinase through thrombolytie therapy, 48 eases in controlled group cured by general medicine therapy. The scores in two groups were assessed by SSS drafted by the National Fourth Conference on Cerebrovaseular Disease before and after treatment and effective rates in two groups were compared. Results There was signifcantly difference in effective rates between treatment group and controlled group （ P 〈 0.05 ）. Conclusion It can gain better effect through thrombolytic therapy in the treatment of acute cerebral infarction than general medicine treatment, and can significantly improve symptoms of neurological deficit, it is worthy of spreading.